Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BeyondMD vs Vida Health

BeyondMD
Graded #189

Higher grade

vs+11.299999999999997
Vida Health
Graded #447

Lower grade

The verdict

BeyondMD takes it — 66.5/100 to 55.2/100.

BeyondMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth clinic offering competitively priced compounded semaglutide and tirzepatide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBeyondMD +30
75
45
Dose & formulationBeyondMD +24
64
40
Clinical oversightVida Health +1
74
75
Labs & monitoringVida Health +8
53
61
FulfillmentBeyondMD +3
65
62
Contract termsEven
55
55
BeyondMD · left barVida Health · right bar

The numbers

MetricBeyondMDVida Health
WeighScore66.5/10055.2/100
GradeCC
Scorecard rank#189#447
Semaglutide$139/mo (starting dose, compounded)Not disclosed
Tirzepatide$209/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
BeyondMD

Graded #189 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Vida Health

Graded #447 · C

Strengths

  • Medical Weight Loss program includes anti-obesity GLP-1 medications
  • Pairs medication with behavioral-health coaching and medical management
  • Whole-person care across chronic conditions, sleep, and nutrition
  • Integrates with major health plans, PBMs, and benefit platforms
  • Established virtual chronic-care platform

Where it loses points

  • Distributed mainly via employers and health plans, not direct cash-pay
  • Access usually requires employer or plan sponsorship
  • No public consumer GLP-1 pricing
  • Clinician credentials not detailed publicly
  • Less suited to consumers wanting direct-to-door GLP-1

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard